AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Nutriband Inc. Common Stock
XNAS · usd
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI BBG00GSMQF67
5.76▼ 0.05 (-0.86%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
5.81
Day's Range
5.71 – 5.94
52-Week Range
2.80 – 9.19
Volume
6,646
Avg Volume
100.1K
Share Statistics
Shares Outstanding
Employees
3
Exchange
XNAS
Listed
2017-06-20
Share count as of September 4, 2026

Nutriband Inc. Common Stock (NTRB) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Nutriband Inc. Common Stock (NTRB)
What is Nutriband Inc. Common Stock's Market Cap?
Nutriband Inc. Common Stock's Market Cap is $70.0M, based on as-reported figures from SEC (XBRL) filings.
What is Nutriband Inc. Common Stock's Price / Sales?
Nutriband Inc. Common Stock's Price / Sales is 30.7×, based on as-reported figures from SEC (XBRL) filings.
What is Nutriband Inc. Common Stock's Revenue (TTM)?
Nutriband Inc. Common Stock's Revenue (TTM) is $2.3M, based on as-reported figures from SEC (XBRL) filings.
What is Nutriband Inc. Common Stock's Net Income (TTM)?
Nutriband Inc. Common Stock's Net Income (TTM) is -$12.8M, based on as-reported figures from SEC (XBRL) filings.
What is Nutriband Inc. Common Stock's EBITDA?
Nutriband Inc. Common Stock's EBITDA is -$12.6M, based on as-reported figures from SEC (XBRL) filings.
What is Nutriband Inc. Common Stock's Diluted EPS (TTM)?
Nutriband Inc. Common Stock's Diluted EPS (TTM) is -1.05, based on as-reported figures from SEC (XBRL) filings.
What is Nutriband Inc. Common Stock's EBITDA Margin?
Nutriband Inc. Common Stock's EBITDA Margin is -554.1%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · NTRBAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJul 31, 2026Apr 30, 2026Jan 31, 2026Oct 31, 2025Jul 31, 2025Apr 30, 2025Jan 31, 2025Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022
Revenue
YoY growth-29.7%-35.1%-37.6%-46.4%
Costs and expenses:
Cost of revenues
Research and development
Selling, general and administrative
Total Costs and Expenses
% of revenue303.6%389.4%354.8%1221.3%
Loss from operations
% of revenue-203.6%-289.4%-254.8%-1121.3%
Other income (expense):
Interest income——
Interest expense
Total other income (expense)
Loss before provision for income taxes
Net loss
% of revenue-201.3%-286.6%-241.6%-1119.0%
Preferred shares dividend——
Net loss available to common stockholders - basic
Net loss available to common stockholders - diluted
Net loss per share attributable to common stockholders - basic
Net loss per share attributable to common stockholders - diluted